Butterfly Network, Inc. (NYSE: BFLY), a leader in digital health and portable ultrasound technology, has announced that its third-generation handheld ultrasound device, the Butterfly iQ3™, has been honored with the Best Medical Technology Award at the 2024 Prix Galien USA Awards, presented by the Galien Foundation.
The Prix Galien Awards, often referred to as the “Nobel Prize of Life Sciences,” recognize groundbreaking achievements in healthcare innovation. Established in 1970, the awards celebrate advancements in drug development, medical technologies, and treatments that improve human health. Butterfly’s iQ3 was chosen for its transformative impact on ultrasound imaging, thanks to its Ultrasound-on-Chip™ technology.
The Butterfly iQ3 builds on the success of its predecessors, offering enhanced features powered by artificial intelligence and advanced image capture capabilities. It is powered by Butterfly’s P4.3 semiconductor, the company’s most powerful Ultrasound-on-Chip™ platform, which enables portable, high-quality imaging for clinicians around the world.
Joseph DeVivo, President and CEO of Butterfly Network, expressed his pride in receiving the award: “This recognition is a testament to the dedication of our team and their commitment to revolutionizing medical imaging. Our Ultrasound-on-Chip™ technology leverages Moore’s Law to deliver cost-effective, high-performance imaging solutions that democratize access to ultrasound globally. By enabling faster, more accurate decision-making, we are empowering healthcare providers to improve patient care on a global scale.”
The 2024 Prix Galien USA Awards also recognized other major industry players such as Pfizer, AstraZeneca, and Daiichi Sankyo, alongside Butterfly.
Michael Rosenblatt, MD, Chair of the Prix Galien USA Awards Committee, congratulated the honorees, saying, “We are proud to celebrate the innovation and dedication of this year’s awardees, whose contributions are making a significant difference in global health.”
For a full list of the 2024 nominees and award winners, visit the Prix Galien Foundation’s website.
About the Galien Foundation
The Galien Foundation’s mission is to recognize and reward excellence in scientific innovation to improve human health. The Prix Galien, which was established in honor of Galien (the father of modern pharmacology), is considered the highest honor in biopharmaceutical research worldwide.
About Butterfly Network
Founded in 2011 by Dr. Jonathan Rothberg, Butterfly Network is transforming medical imaging with its Ultrasound-on-Chip™ technology. The company’s handheld ultrasound devices, including the Butterfly iQ and iQ3, are designed to make high-quality ultrasound affordable, accessible, and easy to use—paving the way for earlier detection and better health outcomes globally. Butterfly’s innovative solutions are used by healthcare practitioners in over 90 countries, helping to bridge gaps in care for millions of people.
